Literature DB >> 15620535

Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC.

G Cannazza1, A Di Stefano, B Mosciatti, D Braghiroli, M Baraldi, F Pinnen, P Sozio, C Benatti, C Parenti.   

Abstract

A high performance liquid chromatography (HPLC) method was developed to detected simultaneously L-dihydroxyphenylalanine (L-DOPA), dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in rat striatum dilaysates following oral administration of L-DOPA or its prodrugs. The chromatographic system uses a reversed-phase C18 column with electrochemical detection at +0.30 V. Mobile phase consisted of 0.05 M citric acid, sodium EDTA 50 microM, sodium octylsulphonate 0.4 nM at pH of 2.9 and 8% methanol (v/v) at a flow rate of 1 ml/min. The calibration curves were linear over the concentration range of 10nm to 100 microM and the lower limits of detections were 125 fmol for L-DOPA, 50 fmol for DOPAC, 250 fmol for DA and 150 fmol for HVA at signal noise to ratio of 3. The repeatability (or intra-day precision), expressed by the relative standard deviation, were better than 4%. The construction of microdialysis probes has been described. The in vitro relative recoveries of each microdialysis probe were evaluated and the results show that they are similar and reproducible for all the analytes with CVs from 1 to 4%. The HPLC-EC method was applied to detect the extracellular levels of L-DOPA, DA, DOPAC and HVA in the striatum dialysates of freely moving rats after oral administration of six new potential L-DOPA prodrugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620535     DOI: 10.1016/j.jpba.2004.09.029

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats.

Authors:  Aiping Wang; Lexi Wang; Kaoxiang Sun; Wanhui Liu; Chunjie Sha; Youxin Li
Journal:  Pharm Res       Date:  2012-05-02       Impact factor: 4.200

2.  Dysregulation in the Brain Protein Profile of Zebrafish Lacking the Parkinson's Disease-Related Protein DJ-1.

Authors:  Amanda J Edson; Helena A Hushagen; Ann Kristin Frøyset; Inga Elda; Essa A Khan; Antonio Di Stefano; Kari E Fladmark
Journal:  Mol Neurobiol       Date:  2019-06-19       Impact factor: 5.590

Review 3.  Review of recent advances in analytical techniques for the determination of neurotransmitters.

Authors:  Maura Perry; Qiang Li; Robert T Kennedy
Journal:  Anal Chim Acta       Date:  2009-09-01       Impact factor: 6.558

4.  (13)C/(15)N-Enriched l-Dopa as a Triple-Resonance NMR Probe to Monitor Neurotransmitter Dopamine in the Brain and Liver Extracts of Mice.

Authors:  Hisatsugu Yamada; Tetsuro Kameda; Yu Kimura; Hirohiko Imai; Tetsuya Matsuda; Shinsuke Sando; Akio Toshimitsu; Yasuhiro Aoyama; Teruyuki Kondo
Journal:  ChemistryOpen       Date:  2015-12-30       Impact factor: 2.911

5.  A rapid method for the determination of dopamine in porcine muscle by pre-column derivatization and HPLC with fluorescence detection.

Authors:  Hong-Xia Zhao; Hui Mu; Yan-Hong Bai; Hu Yu; Ying-Mei Hu
Journal:  J Pharm Anal       Date:  2011-07-22

Review 6.  Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Authors:  Fatma Haddad; Maryam Sawalha; Yahya Khawaja; Anas Najjar; Rafik Karaman
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 7.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.